Clinical Trial Update: Safety and Efficacy Study of A0001 in Subjects With Friedreich's Ataxia [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of A0001 in Friedreich's Ataxia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• A0001

Snippet

Sponsor: Penwest Pharmaceuticals Co. | Conditions: Friedreich's Ataxia | Phase 2 | Status: COMPLETED